Health Care Resource Utilization Following Initiation of a Triptan: A Retrospective Claims Analysis

BACKGROUND: 23 million Americans suffer from migraine headaches, incurring more than $1 billion in direct medical costs each year (with another $13 billion in indirect productivity losses). Triptans are the most common treatment of choice for these patients; however, adherence and persistence to tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Messali, Andrew, Owens, Gary, Bloudek, Lisa, Kori, Shashidhar, Cole, Ashley, Chia, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437956/
https://www.ncbi.nlm.nih.gov/pubmed/24684641
http://dx.doi.org/10.18553/jmcp.2014.20.4.368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437956/
https://www.ncbi.nlm.nih.gov/pubmed/24684641
http://dx.doi.org/10.18553/jmcp.2014.20.4.368

Ejemplares similares